[{"NetIncomeLoss_1_Q2_USD":-31845000.0,"OtherAssetsNoncurrent_0_Q2_USD":41465000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":530181000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":2271630000.0,"Liabilities_0_Q2_USD":1484155000.0,"GainLossOnInvestments_2_Q2_USD":9887000.0,"GainLossOnInvestments_1_Q2_USD":9625000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":16453000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":9251000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":11204000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":-22178000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":-11924000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_Q2_USD":-21695000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q2_USD":-11441000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":67802000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":999000.0,"ContractWithCustomerAssetNetCurrent_0_Q2_USD":27834000.0,"InventoryFinishedGoods_0_Q2_USD":741000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-16440000.0,"IncomeTaxesPaid_2_Q2_USD":49000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-15312000.0,"Depreciation_2_Q2_USD":6360000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":11970000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":367000.0,"AssetsCurrent_0_Q2_USD":2531187000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":976284000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":147009000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":72015000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":5561000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":3012000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":982173000.0,"InterestPaidNet_2_Q2_USD":3093000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-14939000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-21050000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-71221000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-59355000.0,"InventoryRawMaterials_0_Q2_USD":19510000.0,"EarningsPerShareBasic_2_Q2_USD":-0.58,"EarningsPerShareBasic_1_Q2_USD":-0.23,"MinorityInterest_0_Q2_USD":217620000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":9251000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":11204000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":139391000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":139352000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-249000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-149000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-3696000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-439000.0,"NumberOfReportableSegments_2_Q2_Segment":2.0,"CommonStockValue_0_Q2_USD":139000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q2_USD":188000.0,"InvestmentIncomeNet_2_Q2_USD":19459000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-31858000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-80170000.0,"IncreaseDecreaseInInventories_2_Q2_USD":3018000.0,"OtherAssetsCurrent_0_Q2_USD":131015000.0,"CostsAndExpenses_1_Q2_USD":197291000.0,"CostsAndExpenses_2_Q2_USD":391784000.0,"CommonStockSharesIssued_0_Q2_shares":139489405.0,"MinorityInterestPeriodIncreaseDecrease_2_Q2_USD":-22178000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q2_USD":4000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-86066000.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.035,"StockIssuedDuringPeriodValueShareBasedCompensationGross_1_Q2_USD":8800000.0,"StockIssuedDuringPeriodValueShareBasedCompensationGross_2_Q2_USD":16451000.0,"InvestmentIncomeNet_1_Q2_USD":9243000.0,"MinorityInterestPeriodIncreaseDecrease_1_Q2_USD":-11924000.0,"Assets_0_Q2_USD":3078950000.0,"ShareBasedCompensation_2_Q2_USD":89233000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":2800000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":39600000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue_0_Q2_USD":276676000.0,"AmortizationOfFinancingCosts_2_Q2_USD":1236000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_0_Q2_USD":26997000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":11971000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":48442000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":89233000.0,"AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1_0_Q2_Investment":78.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-51728000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":139391000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":139352000.0,"InventoryWorkInProcess_0_Q2_USD":3471000.0,"LiabilitiesCurrent_0_Q2_USD":231341000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":-153106000.0,"AccountsPayableCurrent_0_Q2_USD":7407000.0,"InterestExpense_2_Q2_USD":22163000.0,"InterestExpense_1_Q2_USD":11173000.0,"NetIncomeLoss_2_Q2_USD":-80071000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":172618000.0,"NumberOfOperatingSegments_2_Q2_Segment":2.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":27700000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":1594795000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_0_Q2_USD":249679000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":61900000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_0_Q2_USD":192000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_1_Q2_USD":74000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_2_Q2_USD":82000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.21,"AccruedIncomeTaxesCurrent_0_Q2_USD":27943000.0,"IncreaseDecreaseInContractWithCustomerAsset_2_Q2_USD":-35200000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":530181000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-1064000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":-32491000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.23,"CommonStockSharesOutstanding_0_Q2_shares":139489405.0,"IncreaseDecreaseInOtherCurrentLiabilities_2_Q2_USD":-1968000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":305980000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockSharesAuthorized_0_Q2_shares":300000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":145537000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":278905000.0,"OperatingIncomeLoss_2_Q2_USD":-112879000.0,"OperatingIncomeLoss_1_Q2_USD":-51754000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":-105945000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":-44208000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":90548000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":1818435000.0,"InventoryNet_0_Q2_USD":23722000.0,"StockRepurchasedAndRetiredDuringPeriodValue_2_Q2_USD":90550000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":100401000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-2513000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":3078950000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-878154000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-3842000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":18178000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":448576000.0,"LongTermLoansFromBank_0_Q2_USD":59948000.0,"StockholdersEquity_0_Q2_USD":1377175000.0,"EarningsPerShareDiluted_2_Q2_USD":-0.58,"ProfitLoss_1_Q2_USD":-43769000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":0.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":17807000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":48442000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":89233000.0,"IncreaseDecreaseInOtherEmployeeRelatedLiabilities_2_Q2_USD":-14535000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":22822000.0,"ProfitLoss_2_Q2_USD":-102249000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":-92916000.0,"Ticker":"IONS","CIK":"874015","name":"IONIS PHARMACEUTICALS INC","OfficialName":"Ionis Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"5803570258.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200805"}]